Arcutis Biotherapeutics, Inc. · NASDAQ:ARQT
Peetz Christopher received 4,315 Arcutis Biotherapeutics, Inc. shares as an award (Form 4)
Traded Jul 15, 2026 · Filed Jul 17, 2026
On Jul 15, 2026, Peetz Christopher (Director) received 4,315 Arcutis Biotherapeutics, Inc. shares as an award, leaving 4,315 shares. Filed Jul 17, 2026 (Form 4).
- Awarded
- 4,315 shares
- Holding after
- 4,315 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 15, 2026 | Common Stock | Award | 4,315 | 4,315 | Direct |